retatrutide for type 2 diabetes phase trial 2 is investigational and is not FDA approved. In TRANSCEND Lilly Advances Triple Agonist Retatrutide

It was optional

Pharmacists can guide patients toward the right options based on their specific side effects

Common GLP-1 drugs include: Semaglutide (sold as Ozempic, Wegovy, or Rybelsus) Tirzepatide (sold as Mounjaro or Zepbound) Liraglutide (sold as Victoza or Saxenda) Dulaglutide (sold as Trulicity) Exenatide (sold as Byetta) These medications work by slowing down your digestion

Common medications in this class include: Ozempic (semaglutide) Wegovy (semaglutide) Rybelsus (semaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Trulicity (dulaglutide) While many users experience common, milder side effects like nausea, a growing number of individuals are reporting severe, persistent, and life-altering gastrointestinal injuries